Terheyden, Jan Henrik http://orcid.org/0000-0002-0174-4066
Ometto, Giovanni
Montesano, Giovanni
Wintergerst, Maximilian W. M. http://orcid.org/0000-0002-2766-7038
Langner, Magdalena
Liu, Xiaoxuan http://orcid.org/0000-0002-1286-0038
Keane, Pearse A. http://orcid.org/0000-0002-9239-745X
Crabb, David P. http://orcid.org/0000-0001-8754-3902
Denniston, Alastair K. http://orcid.org/0000-0001-7849-0087
Finger, Robert P.
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 26 May 2020
Accepted: 25 January 2021
First Online: 8 February 2021
Competing interests
: The Department of Ophthalmology, University of Bonn received imaging devices from Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue. JHT: No additional conflicts of interest. GO: None. GM: None. MWMW: Travel grant/reimbursement from DigiSight Technologies, Heine Optotechnik GmbH, ASKIN & CO GmbH and Berlin-Chemie AG, grants from Heine Optotechnik and Berlin-Chemie AG, consultant for Heine Optotechnik GmbH, imaging devices from DigiSight Technologies, D-EYE Srl and Heine Optotechnik GmbH, free analysis from Eyenuk Inc. ML: No additional conflicts of interest. XL: None. PAK: Grants from Allergan, Bayer, Carl Zeiss Meditec, Haag-Streit, Heidelberg Engineering, Novartis, Topcon, consultant for Deepmind. AKD: None. DPC: Speaker fees from Allergan, Bayer, Santen; unrestricted funding from Allergan, Santen; consultancy with Centervue—all outside the remit of the submitted work. RPF: Consultant for Bayer, Novartis, Santen, Opthea, Novelion, Santhera, Inositec, Alimera and RetinaImplant; honoraria from Bayer, Ellex, Alimera.